Effects of the NF-κB Signaling Pathway Inhibitor BAY11-7082 in the Replication of ASFV

African swine fever virus (ASFV) mainly infects the monocyte/macrophage lineage of pigs and regulates the production of cytokines that influence host immune responses. Several studies have reported changes in cytokine production after infection with ASFV, but the regulatory mechanisms have not yet been elucidated. Therefore, the aim of this study was to examine the immune response mechanism of ASFV using transcriptomic and proteomic analyses. Through multi-omics joint analysis, it was found that ASFV infection regulates the expression of the host NF-B signal pathway and related cytokines. Additionally, changes in the NF-kappa B signaling pathway and IL-1 beta and IL-8 expression in porcine alveolar macrophages (PAMs) infected with ASFV were examined. Results show that ASFV infection activates the NF-kappa B signaling pathway and up-regulates the expression of IL-1 beta and IL-8. The NF-kappa B inhibitor BAY11-7082 inhibited the expression profiles of phospho-NF-kappa B p65, p-I kappa B, and MyD88 proteins, and inhibited ASFV-induced NF-kappa B signaling pathway activation. Additionally, the results show that the NF-kappa B inhibitor BAY11-7082 can inhibit the replication of ASFV and can inhibit IL-1 beta and, IL-8 expression. Overall, the findings of this study indicate that ASFV infection activates the NF-kappa B signaling pathway and up-regulates the expression of IL-1 beta and IL-8, and inhibits the replication of ASFV by inhibiting the NF-kappa B signaling pathway and interleukin-1 beta and interleukin-8 production. These findings not only provide new insights into the molecular mechanism of the association between the NF-kappa B signaling pathway and ASFV infection, but also indicate that the NF-kappa B signaling pathway is a potential immunomodulatory pathway that controls ASF.